Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 71335-1460

3 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71335-1460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351460)

Label Image (Lbl713351460)
Label for Raloxifene hydrochloride 60 mg oral film-coated tablet by Bryant Ranch Prepack. The label compares the product to Evista 60 mg tablet by ScieGen Pharmaceuticals. It includes storage instructions to keep at room temperature (20°-25°C) and a warning to keep drugs out of reach of children. The package contains 60 tablets and displays the product NDC 71335-1460-1 with a barcode.*
FDA Label Image

Figure 1: Total Hip Bone Mineral Density Mean Percentage Change From Baseline (Raloxifene Pi 02v1)

Figure 1: Total Hip Bone Mineral Density Mean Percentage Change From Baseline (Raloxifene Pi 02v1)
Two line graphs showing total hip mean percentage change from baseline over 24 months after randomization. The first graph compares Raloxifene and Placebo in all placebo and Raloxifene subjects from two studies (NA and EU). The second graph compares Raloxifene, Placebo, and CE (conjugated estrogens) in hysterectomized women over 24 months. Both graphs indicate percentage change on the y-axis and months after randomization on the x-axis.*
FDA Label Image

Chemical Structure (Raloxifene Pi)

Chemical Structure (Raloxifene Pi)
Chemical structure of raloxifene hydrochloride, showing the molecular arrangement of atoms including a thiochromene core, phenyl groups, hydroxyl substituents, and a piperidine moiety with chloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.